Botanical species · safety record

Achyranthes aspera

The EFSA Compendium of Botanicals holds 4 constituent measurements and 4 adverse-effect records for Achyranthes aspera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Achyranthes aspera L.

4Constituent measurements

4Safety records

5Cited sources

28Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 28 licensed products naming Achyranthes aspera as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Flower extract
Herb top
Herb top and root
Leaf
New material
Root
Root extract
Seed

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Oxalates	Leaves	Fresh	8.5 Percent	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Heart	Unspecified	Solvent extraction	Human (as organism)	Case report	No resolvable identifier
Reproductive	Urogenital	Fruit unspecified	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier
Reproductive	Uterus	Roots and other underground parts	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier
Systemic	Digestive	Leaves	Fresh	—	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gawande, Dinesh Y., Druzhiloysky, Dmitry., Gupta, Raghbir Chand., Poroikov, Vladimir., Goel, Rajesh Kumar. Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn. . Journal of ethnopharmacology, 2017, vol. 202, p. 97-102. DOI
Sanchez Perere, Lic Luz Ma., Alfonso, H. A., Noa, M., Angeles Figueredo, Ma., Gomez, B. C. Intoxication due to achyrantes aspera L. Veterinary and human toxicology, 1995, vol. 37, no. 6, p. 582-582.
Vasudeva, Neeru., Sharma, S K. Estrogenic and pregnancy interceptory effects of Achyranthes aspera Linn. root. . African journal of traditional, complementary, and alternative medicines : ajtcam, 2006, vol. 4, no. 1, p. 7-11.
Gurumani, M., Balamurugan, K. Evaluation of antifertility potential of ethanolic extract of whole plant of achyranthes aspera in female albino rats. International journal of current pharmaceutical review and research, 2014, vol. 5, no. 1, p. 31-36.
Han, ST., Lin, CC. Cardiac toxicity caused by Achyranthes aspera. Veterinary and human toxicology, 2003, vol. 45, no. 4, p. 212-213.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature